# Cardio-Renal Effects of Short-Term Fructose Treatment in Hypertensive Rats: Focused on NO/ROS Balance

**Authors:** Olga PECHANOVA, Radoslava BULKOVA, Stanislava VRANKOVA, Jana KLIMENTOVA, Zuzana GALANDAKOVA, Martina CEBOVA

PMC · DOI: 10.33549/physiolres.935724 · Physiological Research · 2025-12-01

## TL;DR

Short-term fructose intake affects kidney function and lipid levels in hypertensive rats without changing blood pressure.

## Contribution

The study reveals strain-dependent effects of fructose on renal oxidative stress and lipid metabolism in hypertensive rats.

## Key findings

- Fructose increased kidney-to-body-weight ratio and dyslipidemia in spontaneously hypertensive rats.
- Renal NADPH oxidase was upregulated and SOD downregulated in hypertensive rats after fructose treatment.
- NOS activity decreased in the heart and kidney of normotensive rats and the kidney of hypertensive rats.

## Abstract

Short-term fructose exposure may perturb the nitric oxide (NO)/reactive oxygen species (ROS) balance before hemodynamic changes development. Male Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) rats received 10 % fructose in drinking water for 3 weeks or remained on tap water. We assessed systolic blood pressure (tail-cuff), plasma lipid levels, tissue conjugated diene concentrations, protein expression of NADPH oxidase, NF-κB, and SOD (Western blot), and total NO synthase (NOS) activity ([3H]-L-arginine to [3H]-L-citrulline). Fructose did not change blood pressure in either strain, but increased kidney-to-body-weight ratio in SHR. In WKY, plasma HDL level decreased; in SHR, total cholesterol, VLDL, and triglycerides increased. Conjugated diene concentration increased in the kidney of WKY but not in the heart. Fructose upregulated renal NADPH oxidase and downregulated renal SOD in SHR, with no change in cardiac NADPH oxidase. NF-κB protein expression did not change in either tissue. NOS activity decreased in the heart and kidney of WKY and in the kidney of SHR. We can conclude that even moderate, short-term fructose intake induces strain-dependent dyslipidemia and an early shift of the renal redox milieu toward oxidative stress, accompanied by reduced NOS activity, while leaving blood pressure unchanged. The kidney appears more susceptible than the heart, particularly in the hypertensive background, highlighting the NO/ROS axis as an early target for intervention.

## Linked entities

- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1), SOD1 (superoxide dismutase 1), NOS1 (nitric oxide synthase 1)
- **Chemicals:** fructose (PubChem CID 5984), L-arginine (PubChem CID 232), L-citrulline (PubChem CID 833)

## Full-text entities

- **Genes:** Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Khk (ketohexokinase) [NCBI Gene 25659] {aka KETHPRO}, Lep (leptin) [NCBI Gene 25608] {aka OB, obese}, Srebf1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 78968] {aka ADD-1, ADD1, SREBP-1, SREBP-1c, Srebp1}, Nos3 (nitric oxide synthase 3) [NCBI Gene 24600] {aka eNos}, Acat2 (acetyl-CoA acetyltransferase 2) [NCBI Gene 308100] {aka Ab2-076, Acat3}, Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}, Syt1 (synaptotagmin 1) [NCBI Gene 25716] {aka P65}, Slc2a5 (solute carrier family 2 member 5) [NCBI Gene 65197], Slc2a2 (solute carrier family 2 member 2) [NCBI Gene 25351] {aka GTT2, Glut2}, Sod1 (superoxide dismutase 1) [NCBI Gene 24786] {aka CuZnSOD}, Nox4 (NADPH oxidase 4) [NCBI Gene 85431], Calm1 (calmodulin 1) [NCBI Gene 24242] {aka CaMI, Calm, Cam1}, Mlxipl (MLX interacting protein-like) [NCBI Gene 171078] {aka ChREBP, WS-bHLH, Wbscr14, bHLHd14}, Soat2 (sterol O-acyltransferase 2) [NCBI Gene 266770] {aka Acat-2}
- **Diseases:** ectopic fat (MESH:D004620), cardio-renal (MESH:D059347), adiposity (MESH:D018205), renal hypertrophy (MESH:D006984), chronic kidney disease (MESH:D051436), hypertriglyceridemia (MESH:D015228), kidney hypertrophy (MESH:D007674), dyslipidemia (MESH:D050171), inflammation (MESH:D007249), metabolic syndrome (MESH:D024821), cardiovascular disease (MESH:D002318), type 2 diabetes (MESH:D003924), fibrosis (MESH:D005355), hyperuricemia (MESH:D033461), Hypertensive (MESH:D006973)
- **Chemicals:** CHOL (MESH:D002784), acetyl-coenzyme A (MESH:D000105), nicotinamide adenine dinucleotide (MESH:D009243), NADPH (MESH:D009249), FAD (MESH:D005182), L-citrulline (MESH:D002956), NaCl (MESH:D012965), 6-aminouracil (MESH:C013400), HEPES (MESH:D006531), TG (MESH:D014280), CaCl2 (MESH:D002122), EDTA (MESH:D004492), chloroform (MESH:D002725), polyol (MESH:C024617), FMN (MESH:D005486), ATP (MESH:D000255), monosaccharide (MESH:D009005), ROS (MESH:D017382), sucrose (MESH:D013395), EGTA (MESH:D004533), coenzyme A (MESH:D003065), Na (MESH:D012964), FRU (MESH:D005632), NO (MESH:D009569), Chemicals (-), peroxide (MESH:D010545), uric acid (MESH:D014527), nitrogen (MESH:D009584), superoxide (MESH:D013481), Lipid (MESH:D008055), cyclohexane (MESH:C506365), BH4 (MESH:C003402), sugars (MESH:D000073893), methanol (MESH:D000432), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12849779/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12849779/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12849779/full.md

---
Source: https://tomesphere.com/paper/PMC12849779